Amidst an ongoing outbreak of a deadly bird flu virus in livestock, the US Department of Agriculture is doing more to prevent ...

If we don’t invest in technologies like mRNA vaccines for pandemic influenza now, once a virus starts going human-to-human, ...

From the outset of the Trump administration, bird flu, or H5N1 avian influenza, has flown rather conspicuously — and in fact ...

The shift reflects the current public health situation, marked by declines in human cases as well as animal detections.

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Life science companies developing bird flu vaccines and antivirals are gaining attention as the avian influenza subtype H5N1 becomes an increasing concern. The United States is in the midst of an ...

A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as 2.3.4.4b, which ...

While H5N1 does not have high mortality rates in dairy cows, the infection causes decreases milk production and milk quality, ...

Agriculture Minister John Steenhuisen made the announcement during a media briefing on Tuesday, lauding the permit approval ...

The Department of Health and Human Services has defended cuts to vaccine research with statements that mislead on the safety of mRNA technology, despite an extensive history of testing.